New article: Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines. https://t.co/E0nBq5LaZN #AML #leusm #hematology https://t.co/KVCtYuqcZK
RT @OncologyAdvance: Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines-The purpose of this study was to inve…
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines-The purpose of this study was to investigate the occurrence and develop a risk score for heart failure (HF) in acute leukemia https://t.co/JxPinojEZp #SoMe #medtwitter #MedEd
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines-The purpose of this study was to investigate the occurrence and develop a risk score for heart failure (HF) in acute leukemia https://t.co/JqUyPVqK4L #SoMe #medtwitter #MedEd
RT @CampbellMDPhD: Risk Score for heart failure development in acute leukemia from @JACCJournals https://t.co/xXtWHusm6A #CardioOnc #cardio…
Risk Score for heart failure development in acute leukemia from @JACCJournals https://t.co/xXtWHusm6A #CardioOnc #cardiotwitter https://t.co/wapjIpDzG2
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @EmmanuelScatu: Innovador Score que estratifica el riesgo de #HF en pacientes con leucemia tratados con antraciclinas. Refuerza la neces…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
RT @EmmanuelScatu: Innovador Score que estratifica el riesgo de #HF en pacientes con leucemia tratados con antraciclinas. Refuerza la neces…
Innovador Score que estratifica el riesgo de #HF en pacientes con leucemia tratados con antraciclinas. Refuerza la necesidad de pesquisar la afección miocárdica por quimioterapia mediante parámetros de #cvEcho. #echofirst @echocardiac @SIAC_cardio @CardiOn
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @onco_cardiology: Very interesting work including GLS with hard endpoints. @dineshpmcc1 #JACCCardioOnc https://t.co/7Rnr2rsCfr
RT @SABOURETCardio: Your opinion ? @AntaklyY @AnnabelleJagu @djc795 @DrABINASR @rahatheart1 @drbrowncares @ShelleyZieroth @GiuseppeGalati_…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @onco_cardiology: Very interesting work including GLS with hard endpoints. @dineshpmcc1 #JACCCardioOnc https://t.co/7Rnr2rsCfr
Very interesting work including GLS with hard endpoints. @dineshpmcc1 #JACCCardioOnc
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
🔹Baseline risk score to determine risk of new onset HF in patients with acute leukemia, incluiding echovariables like Strain
RT @SABOURETCardio: Your opinion ? @AntaklyY @AnnabelleJagu @djc795 @DrABINASR @rahatheart1 @drbrowncares @ShelleyZieroth @GiuseppeGalati_…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
RT @SABOURETCardio: Your opinion ? @AntaklyY @AnnabelleJagu @djc795 @DrABINASR @rahatheart1 @drbrowncares @ShelleyZieroth @GiuseppeGalati_…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
RT @pedschwartzmann: Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduar…
Very interesting tool for risk stratification in #cardio oncology! @JACCJournals @md_arianemacedo @ornelasce @ACREduardo #gbco
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
RT @JACCJournals: A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leuk…
A score based on baseline clinical and #cvEcho variables, including GLS can help in evlauting #heartfailure risk in #leukemia patients following treatment with anthracyclines. #JACCCardioOnc @PennCardiology https://t.co/K56IIvCiEM https://t.co/2TLddhQq8u
RT @maljurf100: Study of symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines - After adjustment for age and le…
RT @maljurf100: Study of symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines - After adjustment for age and le…
Study of symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines - After adjustment for age and leukemia type, only global longitudinal strain(GLS) was significantly associated with all-cause mortality https://t.co/g9X3ZMvCPJ
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @EelKat: Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines https://t.co/knmOjuTxnx #jacccardioonc
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @venkmurthy: Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology https:/…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @EelKat: Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines https://t.co/knmOjuTxnx #jacccardioonc
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines https://t.co/knmOjuTxnx #jacccardioonc
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @venkmurthy: Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology https:/…
RT @venkmurthy: Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology https:/…
Well written commentary on the issues with defining and diagnosing anthracycline cardiotoxicity by @onco_cardiology
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
RT @onco_cardiology: I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @ma…
I had the privilege of writing ✍️ this editorial👉🏼 https://t.co/s4834fJUey with @PalaskasN & @cezar_ciliescu about @mariellesc1 nice paper 👉🏼https://t.co/clRzz0yZuj of baseline predictors of symptomatic HF in patients w/ leukemia treated with Anthracy
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines https://t.co/cDh5stsERk
Will your patient with acute #leukemia started on treatment with anthracyclines develop #HF? There is a risk score for that now. Cohort of 450 patients, 40 of which had symptomatic #HF. Need larger study, but very interesting start. @JACCJournals http
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines https://t.co/8y8CTW5vOn https://t.co/C8LJpmbe66